AM 4113 is primarily studied for its potential applications in neuroscience and pharmacology, particularly in the investigation of cannabinoid receptors. It acts as a selective antagonist for the CB1 receptor, making it a valuable tool in research focused on understanding the endocannabinoid system. Its ability to block CB1 receptors allows scientists to explore the role of these receptors in various physiological processes, including pain modulation, appetite regulation, and neuroprotection. Additionally, AM 4113 is used in preclinical studies to examine the effects of cannabinoid receptor inhibition, which could contribute to the development of therapeutic strategies for conditions such as obesity, addiction, and neurodegenerative diseases. Its specificity and potency make it a key compound in advancing the understanding of cannabinoid-mediated pathways.